Ironwood Pharmaceuticals (IRWD) said late Thursday it has received a non-compliance notice from Nasdaq over its delay in filing annual report for the year ended Dec. 31, 2024, with the Securities and Exchange Commission.
Ironwood said it plans to file the report as soon as practicable. It has until May 20 to submit a plan to regain compliance.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments